Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

RPRXRPRX
Showing 8 of 25 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ROYALTY PHARMA PLC

GEODE CAPITAL MANAGEMENT, LLC holds 8.1M shares of RPRX (ROYALTY PHARMA PLC), worth $450.6M as of 2026-Q2. The position was increased (+2.4% shares). RPRX represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$450.6M

Current Shares

8.1M

Total Value Change

+$245M

Total Shares Change

+792,262

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
8.1M
+2.4%
$450.6M0.0%$55.85
32
2026-Q1
Increased
7.9M
+1.9%
$376.5M0.0%$47.57
32
2025-Q4
Increased
7.7M
+1.3%
$297.5M0.0%$38.12
31
2025-Q3
Decreased
7.6M
-6.8%
$268M0.0%$34.61
0
2025-Q2
Increased
8.2M
+2.2%
$299.5M0.0%$35.13
32
2025-Q1
Increased
8M
+9.4%
$253.5M0.0%$30.15
34
2024-Q4
Increased
7.3M
+0.6%
$186.8M0.0%$24.55
31
2024-Q3
Increased
7.3M
+6.1%
$205.6M0.0%$27.00
33

Other major holders of RPRX: MORGAN STANLEY, ADAGE CAPITAL PARTNERS GP, L.L.C., Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used